| Company/Division name | KB Biotech Solutions |
| Parent company | Anhui Chem-bright Bioengineering Co. Ltd. |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 100 |
| Year reshoring announced: | 2017 |
| Year reshoring implemented or to be implemented: | 2018 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 12 |
| Country(ies) from which reshored: | China |
| City reshored to: | Dillon |
| State(s) reshored to: | SC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Biomedicine |
| What domestic positive factors made reshoring more attractive? | Customer responsiveness improvement, Government Incentives, Infrastructure (transport, internet, power), Proximity to customers/market, Skilled workforce availability/training |
| Government Incentive dollar amount: | $150,000 grant |
